InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: None

Monday, 05/07/2012 1:25:30 PM

Monday, May 07, 2012 1:25:30 PM

Post# of 146196
No one seems to get that this patent approval is not the one or scope the docs were expecting. This approval is for the ENTIRE platform. This approval, if I read the PR correctly, means Allexcel, and therefore NNVC, owns the exclusive rights for the entire base and that no one can legally reverse engineer the platform and simply slap a new set of ligands to the structure and call it an improvement. This protection extends to all countries in the WPO. This news is huge, and it makes the follow-on patent applications for antiviral use a slam dunk and nothing more than a possible strategy for extending patent protection a few more years.

The company owns the entire approach! This ownership will include the original intent for the technology, a therapeutic courier for targeted drug delivery such as RNA therapies.


This is huge!

H5N1 Virus Particles

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News